JSW Steel may seek stay on SC verdict in Bhushan Power case; Nuvama sees limited long-term downside in stock price
By Markets Desk Published on May 4, 2025, 14:27 IST
Following the Supreme Court's decision to scrap JSW Steel's ₹19,700 crore resolution plan for Bhushan Power and Steel and direct creditors to return the amount within two months, brokerage Nuvama Institutional Equities believes the company is likely to file a review petition, seek a stay order, and appeal to a larger bench.
JSW Steel had paid ₹197 billion (₹19,700 crore) to acquire Bhushan Power under the Insolvency and Bankruptcy Code (IBC), a transaction now under question after the apex court ruled that the resolution plan violated IBC norms—both in terms of timely implementation and the use of optionally convertible debentures (OCDs) as part of the funding structure.
Despite the legal setback, Nuvama maintains that the sharp fall in JSW Steel's stock price on May 2 already factors in much of the negative news. The brokerage further opines that it will be extremely difficult for the consortium of creditors to unwind the complex transaction, especially given the time elapsed and capacity upgrades already undertaken by JSW Steel.
In a worst-case scenario, assuming the company loses control of Bhushan Power and receives only the ₹19,700 crore back, without any compensation for its post-acquisition investments, Nuvama estimates a reduction of ₹114 billion (₹47/share) in its fair value.
The brokerage expects the legal process to be protracted and does not rule out interim relief through a stay or partial reversal of the ruling. Until more clarity emerges, the case will remain a legal and investor overhang for India's largest private sector steelmaker.
Disclaimer: The above views are those of the brokerage and not the publication. Investors are advised to consult a certified financial advisor before making investment decisions.
Markets Desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
a day ago
- Business Upturn
Jefferies raises Supreme Industries target to Rs 5,150 on PVC bottoming optimism
By Markets Desk Published on June 13, 2025, 08:19 IST Jefferies has raised its target price for Supreme Industries to ₹5,150 while maintaining a 'Buy' rating, citing that PVC prices are nearing their lowest level in 15 years. At ~$700/MT, the brokerage believes the input cost environment is highly favourable and should support channel restocking. The firm estimates that construction accounts for 45% of Supreme Industries' sales. With the prospect of lower mortgage rates in FY26, the volume growth outlook appears bright. Jefferies forecasts volume growth of over 10% for FY26, coupled with an over 100 basis point operating margin expansion to 15%. Disclaimer: The views expressed above are those of Jefferies. This article does not constitute a recommendation by this publication. Ahmedabad Plane Crash Markets Desk at
Business Upturn
2 days ago
- Business Upturn
Nomura upbeat on Dr. Reddy's long-term prospects; maintains ‘Buy' call with Rs 1,575 target
By Markets Desk Published on June 12, 2025, 07:38 IST Nomura has maintained its Buy rating on Dr. Reddy's Laboratories, setting a target price of ₹1,575, following the company's strategic roadmap shared during a recent management interaction. The company laid out four key levers to sustain growth and profitability beyond the gRevlimid opportunity, including: Sustained growth in the base business, Significant upside potential from semaglutide, the blockbuster diabetes and weight-loss drug, Capacity to undertake selective acquisitions in the $2–2.5 billion range, and A strong focus on cost rationalisation, with plans to reduce operating expenses by 500 basis points — from 37% to 32% of sales — thereby maintaining EBITDA margins around 25%. Dr. Reddy's, a major Indian pharmaceutical company with a strong global presence, has expanded its footprint across generics, biosimilars, and active pharmaceutical ingredients (APIs). It has also been building its presence in high-value markets like the US, Europe, and emerging markets through a mix of organic growth and strategic deals. Nomura believes the combination of margin optimisation, pipeline monetisation (including complex generics like semaglutide), and balance sheet flexibility places the company in a strong position for long-term value creation. Disclaimer: The views and target prices mentioned are as stated by Nomura and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
Business Upturn
2 days ago
- Business Upturn
Jefferies bullish on real estate pre-sales; sees rate cuts boosting mid-income housing
By Markets Desk Published on June 12, 2025, 07:49 IST Jefferies has turned increasingly constructive on the Indian real estate sector, expecting pre-sales growth for listed developers to rise over 20% in FY26, up from 15% in FY25. The brokerage cited strong project launch activity in Q1FY26, which lends credibility to developer guidance, contrasting the patchy execution seen last year. It further noted that the recent rate cuts by the RBI are a relief for the mid-income and affordable housing segments, improving affordability and mortgage flow. Despite the sharp rally in property stocks over the past year, Jefferies pointed out that most names continue to trade in line with their 5-year NAV premiums, leaving room for re-rating if visible sales growth persists. Top picks include DLF, Godrej Properties (GPL), and Lodha (Macrotech Developers). Disclaimer: The views and target prices mentioned are as stated by Jefferies and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
